Skip to main content
Top
Published in: Surgery Today 12/2015

01-12-2015 | Case Report

Endograft infection after hybrid surgery for chronic Stanford type B aortic dissection: endograft infection and treatment

Authors: Manabu Yamasaki, Kohei Abe, Hiroyasu Misumi, Joji Ito, Yusuke Nakanishi, Kohei Kawazoe

Published in: Surgery Today | Issue 12/2015

Login to get access

Abstract

While the incidence of endograft infection is very low, the treatment is difficult when it occurs. We herein present the case of a 52-year-old male who had undergone a graft replacement in the proximal descending thoracic aorta for dissected aortic aneurysm (DA) 6 years previously and hybrid surgery 2 years previously, which consisted of an abdominal graft replacement, visceral and renal debranching surgery and endovascular surgery for a ruptured abdominal DA and residual thoracoabdominal DA. Following collapse from septic shock due to an endograft infection, we performed an in situ reconstruction of the entire thoracoabdominal aorta following intensive antibiotic therapy and 2 preoperative CT-guided percutaneous interventions. He was discharged 4 weeks after the surgery without any complications.
Literature
1.
go back to reference Cernohorsky P, Reijnen MM, Tielliu IF, van Sterkenburg SM, van den Dungen JJ, Zeebregts CJ. The relevance of aortic endograft prosthetic infection. J Vasc Surg. 2011;54:327–33.CrossRefPubMed Cernohorsky P, Reijnen MM, Tielliu IF, van Sterkenburg SM, van den Dungen JJ, Zeebregts CJ. The relevance of aortic endograft prosthetic infection. J Vasc Surg. 2011;54:327–33.CrossRefPubMed
2.
go back to reference Chiesa R, Tshomba Y, Kahlberg A, Marone EM, Civilini E, Coppi G, et al. Management of thoracic endograft infection. J Cardiovasc Surg (Torino). 2010;51:15–31. Chiesa R, Tshomba Y, Kahlberg A, Marone EM, Civilini E, Coppi G, et al. Management of thoracic endograft infection. J Cardiovasc Surg (Torino). 2010;51:15–31.
3.
go back to reference Numan F, Gulsen F, Solak S, Cantasdemir M. Management of endograft infections. J Cardiovasc Surg (Torino). 2010;52:205–23. Numan F, Gulsen F, Solak S, Cantasdemir M. Management of endograft infections. J Cardiovasc Surg (Torino). 2010;52:205–23.
4.
go back to reference Igari K, Kudo T, Toyofuku T, Jibiki M, Sugano N, Inoue Y. Treatment strategies for aortic and peripheral prosthetic graft infection. Surg Today. 2014;44(3):466–71.CrossRefPubMed Igari K, Kudo T, Toyofuku T, Jibiki M, Sugano N, Inoue Y. Treatment strategies for aortic and peripheral prosthetic graft infection. Surg Today. 2014;44(3):466–71.CrossRefPubMed
5.
go back to reference Saleem BR, Berger P, Zeebregts CJ, Slart RH, Verhoeven EL, van den Dungen JJ. Periaortic endograft infection due to Listeria monocytogenes treated with graft preservation. J Vasc Surg. 2008;47:635–7.CrossRefPubMed Saleem BR, Berger P, Zeebregts CJ, Slart RH, Verhoeven EL, van den Dungen JJ. Periaortic endograft infection due to Listeria monocytogenes treated with graft preservation. J Vasc Surg. 2008;47:635–7.CrossRefPubMed
6.
go back to reference Bruggink JL, Slart RH, Pol JA, Reijnen MM, Zeebregts CJ. Current role of imaging in diagnosing aortic graft infections. Semin Vasc Surg. 2010;24:182–90.CrossRef Bruggink JL, Slart RH, Pol JA, Reijnen MM, Zeebregts CJ. Current role of imaging in diagnosing aortic graft infections. Semin Vasc Surg. 2010;24:182–90.CrossRef
7.
go back to reference O’Connor S, Andrew P, Batt M, Becquemin JP. A systematic review and meta-analysis of treatments for aortic graft infection. J Vasc Surg. 2006;44:38–45.CrossRefPubMed O’Connor S, Andrew P, Batt M, Becquemin JP. A systematic review and meta-analysis of treatments for aortic graft infection. J Vasc Surg. 2006;44:38–45.CrossRefPubMed
8.
go back to reference Earnshaw JJ. The current role of rifampicin-impregnated grafts: pragmatism versus science. Eur J Vasc Endovasc Surg. 2000;20:409–12.CrossRefPubMed Earnshaw JJ. The current role of rifampicin-impregnated grafts: pragmatism versus science. Eur J Vasc Endovasc Surg. 2000;20:409–12.CrossRefPubMed
9.
go back to reference Lachapelle K, Graham AM, Symes JF. Antibacterial activity, antibiotic retention, and infection resistance of a rifampin-impregnated gelatin-sealed Dacron graft. J Vasc Surg. 1994;19:675–82.CrossRefPubMed Lachapelle K, Graham AM, Symes JF. Antibacterial activity, antibiotic retention, and infection resistance of a rifampin-impregnated gelatin-sealed Dacron graft. J Vasc Surg. 1994;19:675–82.CrossRefPubMed
10.
go back to reference Sasaki Yuki. The in vitro research of bacterial invasion of prosthetic vascular grafts: comparison of elastomer-sealed and gelatin-coated Dacron vascular grafts. Surg Today. 2014;44(8):1542–7.PubMedCentralCrossRefPubMed Sasaki Yuki. The in vitro research of bacterial invasion of prosthetic vascular grafts: comparison of elastomer-sealed and gelatin-coated Dacron vascular grafts. Surg Today. 2014;44(8):1542–7.PubMedCentralCrossRefPubMed
Metadata
Title
Endograft infection after hybrid surgery for chronic Stanford type B aortic dissection: endograft infection and treatment
Authors
Manabu Yamasaki
Kohei Abe
Hiroyasu Misumi
Joji Ito
Yusuke Nakanishi
Kohei Kawazoe
Publication date
01-12-2015
Publisher
Springer Japan
Published in
Surgery Today / Issue 12/2015
Print ISSN: 0941-1291
Electronic ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-015-1148-9

Other articles of this Issue 12/2015

Surgery Today 12/2015 Go to the issue